GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BML Inc (OTCPK:BMLKF) » Definitions » Long-Term Capital Lease Obligation

BML (BMLKF) Long-Term Capital Lease Obligation : $0.0 Mil (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is BML Long-Term Capital Lease Obligation?

BML's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.0 Mil.

BML's annual Long-Term Capital Lease Obligation increased from Mar. 2022 ($18.0 Mil) to Mar. 2023 ($20.9 Mil) and increased from Mar. 2023 ($20.9 Mil) to Mar. 2024 ($24.9 Mil).

BML Long-Term Capital Lease Obligation Historical Data

The historical data trend for BML's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BML Long-Term Capital Lease Obligation Chart

BML Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.43 18.74 18.01 20.85 24.91

BML Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.85 - - - 24.91

BML  (OTCPK:BMLKF) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

BML Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of BML's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

BML (BMLKF) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BML Inc (OTCPK:BMLKF) » Definitions » Long-Term Capital Lease Obligation
Comparable Companies
TSE:4544 TSE:2395 TSE:2309 TSE:4671 TSE:7707 TSE:3386 TSE:2397 TSE:6090 TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN LH DGX
Traded in Other Exchanges
4694:Japan
Address
5-21-3 Sendagaya, Shibuya-ku, Tokyo, JPN, 1510051
Website
http://www.bml.co.jp
BML Inc provides laboratory testing services in Japan through a network of regional facilities. Its core clinical testing business provides a range of general and specialty laboratory tests, as well as microbiological tests that can be used for applications like food sanitation and environmental analysis. BML often uses automated systems to process and analyze these test samples. In addition to its clinical testing business, BML also has a medical information systems business and a genome-related business. The medical information systems business provides electronic medical charts and information systems that can be used in conjunction with its laboratory tests. The genome business provides gene analysis services.